13F filing recap · Q1 2026
What did Dodge & Cox buy in Q1 2026?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every Dodge & Cox account, including accounts that belong to no fund below.
Stock value
$181.98B
Positions
222
Estimated turnover
14.6%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Dodge & Cox opened new positions in Sunbelt Rentals Holdings, Roper Technologies, Novo Nordisk, Versant Media Group, Astrazeneca, BBB Foods, and Halliburton. The firm exited Astrazeneca, Echostar, Idex, PayPal, Vanguard Index Funds, Amrize, and Grupo Cibest. Notable increases included Microsoft, Booking Holdings, Brookfield Corporation, Arthur J. Gallagher, First Citizens Bancshares, Carrier Global, Coupang, and Transunion. The firm substantially reduced Fedex, Sanofi, and General Electric, while trimming CVS Health, GSK, Baker Hughes, Norfolk Southern, and others.